STAAR Surgical - 15 Year Stock Price History | STAA
Historical daily share price chart and data for STAAR Surgical since 2011 adjusted for splits and dividends. The latest closing stock price for STAAR Surgical as of April 09, 2026 is 25.21.
- The all-time high STAAR Surgical stock closing price was 162.68 on September 07, 2021.
- The STAAR Surgical 52-week high stock price is 30.81, which is 22.2% above the current share price.
- The STAAR Surgical 52-week low stock price is 15.42, which is 38.8% below the current share price.
- The average STAAR Surgical stock price for the last 52 weeks is 21.80.
| STAAR Surgical Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 19.2843 | 23.6000 | 25.2100 | 16.1000 | 25.2100 | 9.18% |
| 2025 | 21.8880 | 24.1000 | 28.5700 | 15.0900 | 23.0900 | -4.94% |
| 2024 | 35.5491 | 29.7300 | 52.2500 | 23.9300 | 24.2900 | -22.17% |
| 2023 | 52.1430 | 51.2500 | 79.3400 | 30.6000 | 31.2100 | -35.70% |
| 2022 | 71.8756 | 93.5000 | 111.5800 | 46.8200 | 48.5400 | -46.83% |
| 2021 | 119.9534 | 81.5900 | 162.6800 | 78.5000 | 91.3000 | 15.25% |
| 2020 | 50.5657 | 34.7900 | 82.7800 | 25.0100 | 79.2200 | 125.25% |
| 2019 | 31.8791 | 31.1100 | 40.7800 | 23.0800 | 35.1700 | 10.22% |
| 2018 | 29.8179 | 15.9000 | 50.6500 | 13.9500 | 31.9100 | 105.87% |
| 2017 | 11.4477 | 10.7000 | 17.4000 | 9.1000 | 15.5000 | 42.86% |
| 2016 | 7.8624 | 7.1200 | 11.4500 | 5.1200 | 10.8500 | 51.96% |
| 2015 | 8.2370 | 9.0300 | 10.6300 | 5.7100 | 7.1400 | -21.62% |
| 2014 | 13.4890 | 15.8700 | 19.3500 | 8.6000 | 9.1100 | -43.73% |
| 2013 | 9.7707 | 6.1900 | 16.2300 | 5.2000 | 16.1900 | 165.41% |
| 2012 | 8.3059 | 10.5700 | 11.3700 | 5.0500 | 6.1000 | -41.85% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.801B | $0.314B |
| Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $114.495B | 24.87 |
| Cardinal Health (CAH) | United States | $51.955B | 22.98 |
| Becton Dickinson (BDX) | United States | $50.083B | 12.65 |
| West Pharmaceutical Services (WST) | United States | $18.021B | 34.36 |
| Cooper (COO) | United States | $16.264B | 20.09 |
| Align Technology (ALGN) | United States | $13.401B | 22.75 |
| Henry Schein (HSIC) | United States | $9.205B | 16.22 |
| Merit Medical Systems (MMSI) | United States | $4.842B | 23.81 |
| DENTSPLY SIRONA (XRAY) | United States | $2.583B | 8.20 |
| CONMED (CNMD) | United States | $1.294B | 9.07 |
| Pro-Dex (PDEX) | United States | $0.127B | 15.07 |
| Lifevantage (LFVN) | United States | $0.064B | 6.62 |
| Axe Compute (AGPU) | United States | $0.008B | 0.00 |